Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

30 Oct 2025 · Pharmaceutical legislation

Meeting with Liesbet Sommen (Member of the European Parliament) and 4 other interest representatives

23 Oct 2025 · Pharmaceutical legislation + Critical Medicines Act

Meeting with Kris Van Dijck (Member of the European Parliament)

22 Oct 2025 · Radioligand Therapy (RLT)

Meeting with Olivér Várhelyi (Commissioner) and 29 other attendees

2 Oct 2025 · All pressing portfolio topics

Meeting with Tomislav Sokol (Member of the European Parliament, Rapporteur)

23 Sept 2025 · Health policy

Meeting with Tiemo Wölken (Member of the European Parliament, Shadow rapporteur)

23 Sept 2025 · Critical Medicines Act

Meeting with Vincenzo Matano (Cabinet of Executive Vice-President Raffaele Fitto) and 2 other interest representatives

17 Sept 2025 · Introductory Meeting on Coalizione VITA Activities

Response to Commission Communication on a EU Cardiovascular Health Plan

12 Sept 2025

Meeting with Vilija Sysaite (Cabinet of Executive Vice-President Stéphane Séjourné)

4 Sept 2025 · European competitiveness aspects

Meeting with Lukas Mandl (Member of the European Parliament)

9 Jul 2025 · Pharma Industry, Competitiveness

Meeting with Maya Matthews (Head of Unit Health and Food Safety)

3 Jun 2025 · The role of the Commission was here to facilitate the exchange between Novartis and the HTA Coordination Group Chairs about a medicinal product sent for joint clinical assessment

Meeting with Elena Nevado Del Campo (Member of the European Parliament)

28 May 2025 · Radioligandos

Meeting with Katarina Koszeghy (Cabinet of Commissioner Wopke Hoekstra) and 6 other interest representatives

26 May 2025 · Exchange of views on the need and prospects for simplification in Pillar 2, in particular in light of the current situation with the US

Meeting with Bernardus Zuijdendorp (Head of Unit Taxation and Customs Union) and 5 other interest representatives

26 May 2025 · Exchange of views on the need and prospects for simplification in Pillar 2, in particular in light of the current situation with the US

Meeting with Laurent Muschel (Director Health Emergency Preparedness and Response Authority)

13 May 2025 · Bilateral meeting between Novartis and HERA on international coordination, legislation, innovation

Meeting with Hoa-Binh Adjemian (Head of Unit Enlargement and Eastern Neighbourhood)

11 Apr 2025 · Engagement regarding Novartis activities in Serbia and signature of an MoU with the Serbian Government

Meeting with Viktória Ferenc (Member of the European Parliament)

18 Mar 2025 · Introduction, exchange of views

Meeting with Jessika Roswall (Commissioner) and 1 other attendee

15 Mar 2025 · Impact of EU environmental policies on the life science sector

Meeting with Olivier Chastel (Member of the European Parliament)

13 Mar 2025 · Politique de santé de l'Union européenne

Meeting with Ana Rita Lopes Ramos (Head of Unit Energy) and RPP Group

11 Mar 2025 · Discussion on Supporting Therapeutic Radiopharmaceuticals Innovation

Meeting with Olivér Várhelyi (Commissioner) and 5 other attendees

26 Feb 2025 · Healthcare, biotech and agri-food policies

Meeting with Nicolás González Casares (Member of the European Parliament)

18 Feb 2025 · Health

Meeting with András Tivadar Kulja (Member of the European Parliament) and F. Hoffmann-La Roche Ltd

18 Feb 2025 · Pharmaceutical Package

Meeting with Katri Teedumäe (Cabinet of Commissioner Olivér Várhelyi), Laszlo Andrejko (Cabinet of Commissioner Olivér Várhelyi)

18 Feb 2025 · EU health policy

Meeting with Raúl De La Hoz Quintano (Member of the European Parliament) and European Food Forum

18 Feb 2025 · Introduction

Meeting with Veronica Manfredi (Director Environment)

11 Feb 2025 · Exchange of views on the Urban Waste Water Treatment Directive and the Mercury Regulation

Meeting with Kerstin Jorna (Director-General Internal Market, Industry, Entrepreneurship and SMEs)

7 Jan 2025 · Exchange of views on biomanufacturing, environmental regulations in the EU, upcoming Biotech Act, Unitary patent and SPC.

Meeting with Irena Joveva (Member of the European Parliament)

22 Nov 2024 · Future of cancer care

Meeting with Sakis Arnaoutoglou (Member of the European Parliament) and AstraZeneca PLC

21 Nov 2024 · Pharma industry, innovations and environmental impacts

Meeting with Jussi Saramo (Member of the European Parliament)

21 Nov 2024 · Lääkesääntely

Meeting with Kristian Vigenin (Member of the European Parliament)

21 Nov 2024 · Implications of pharma legislation for Bulgaria

Meeting with Wouter Beke (Member of the European Parliament)

21 Nov 2024 · EU Pharmaceutical Legislation

Meeting with Elena Nevado Del Campo (Member of the European Parliament)

21 Nov 2024 · Prioridades medioambientales del sector

Meeting with Elsi Katainen (Member of the European Parliament)

21 Nov 2024 · Lääkemarkkinoiden sääntely

Meeting with Pietro Fiocchi (Member of the European Parliament)

21 Nov 2024 · Pharmaceutical legislation

Meeting with Niels Flemming Hansen (Member of the European Parliament)

21 Nov 2024 · A pharmaceutical strategy for Europe

Meeting with Veronika Cifrová Ostrihoňová (Member of the European Parliament)

20 Nov 2024 · EU's pharmaceutical legislation, Women's health

Meeting with Stine Bosse (Member of the European Parliament, Committee chair)

20 Nov 2024 · European health policy

Meeting with Ana Miguel Pedro (Member of the European Parliament)

20 Nov 2024 · Indústria Farmacêutica

Meeting with Bruno Tobback (Member of the European Parliament)

20 Nov 2024 · The European Pharmaceutical Industry: challenges and the need for steady supply chains for critical medicines

Meeting with Anna Stürgkh (Member of the European Parliament) and Bertelsmann SE & Co. KGaA

20 Nov 2024 · General exchange

Meeting with Tomislav Sokol (Member of the European Parliament) and 3 other interest representatives

19 Nov 2024 · Health policy

Meeting with Francesco Torselli (Member of the European Parliament)

19 Nov 2024 · Incontro conoscitivo per discutere delle sfide e prospettive del settore sanitario italiano alla luce della normativa europea

Meeting with Andreas Glück (Member of the European Parliament) and Boehringer Ingelheim

4 Nov 2024 · Health

Meeting with Oliver Schenk (Member of the European Parliament) and 4 other interest representatives

4 Nov 2024 · Pharmastandort Deutschland

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 with regard to the procedures for joint scientific consultations on medicinal products for human use at Union level

28 Oct 2024

Meeting with Ingeborg Ter Laak (Member of the European Parliament)

18 Oct 2024 · Radioligand Therapy

Meeting with Sander Smit (Member of the European Parliament) and SUEZ Group

18 Oct 2024 · ENVI

Meeting with Sophia Kircher (Member of the European Parliament)

3 Oct 2024 · Urban Waste Water Treatment Directive

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 of the European Parliament and of the Council, detailed procedural rules for the cooperation of the Member State Coordination Group on Health Technology Assessment and the Commission with the European Medicines Agency in the form of exchange of information as regards the joint clinical assessment of medicinal products and medical devices and in vitro diagnostic medical devices and as regards the joint scientific consultation on medicinal products and medical devices

24 Jul 2024

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 of the European Parliament and of the Council as regards the management of conflicts of interest in the joint work of the Member State Coordination Group on Health Technology Assessment and its subgroups

26 Jun 2024

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medicinal products for human use at Union level, as well as templates for those joint clinical assessments

2 Apr 2024

Meeting with Stelios Kympouropoulos (Member of the European Parliament)

20 Mar 2024 · rare diseases

Meeting with Nathalie Colin-Oesterlé (Member of the European Parliament)

25 Jan 2024 · Pharmaceutical review

Meeting with Ondřej Knotek (Member of the European Parliament)

13 Dec 2023 · Pharmaceutical package and cardiovascular diseases

Meeting with Tomislav Sokol (Member of the European Parliament)

13 Dec 2023 · CVD

Meeting with Pascal Arimont (Member of the European Parliament) and European Society of Cardiology

13 Dec 2023 · Prevention and non-communicable diseases - cardiovascular health checks

Meeting with Milan Brglez (Member of the European Parliament)

14 Nov 2023 · Pharmaceutical Legislation Package

Meeting with Edina Tóth (Member of the European Parliament)

7 Nov 2023 · Upcoming topics in ENVI Committee

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)

7 Nov 2023 · Directive on Medicinal products for human use

Meeting with Klemen Grošelj (Member of the European Parliament)

7 Nov 2023 · A Pharmaceutical Strategy for Europe

Meeting with Franc Bogovič (Member of the European Parliament)

7 Nov 2023 · Discussion on the open issues in the EU pharmaceutical sector

Meeting with Salvatore De Meo (Member of the European Parliament)

7 Nov 2023 · Pharmaceutical sector

Meeting with Sirpa Pietikäinen (Member of the European Parliament)

7 Nov 2023 · Pharmaceutical Package

Meeting with Maria da Graça Carvalho (Member of the European Parliament)

7 Nov 2023 · Reform of the EU pharmaceutical legislation

Meeting with Ljudmila Novak (Member of the European Parliament)

7 Nov 2023 · Pharmaceutical Legislation Package

Meeting with Silvia Modig (Member of the European Parliament)

7 Nov 2023 · Topical Issues (staff level)

Meeting with Deirdre Clune (Member of the European Parliament) and MEDICINES FOR EUROPE

7 Nov 2023 · Pharmaceutical Package

Meeting with Dolors Montserrat (Member of the European Parliament) and MEDICINES FOR EUROPE

6 Nov 2023 · Revision of the pharmaceutical legislation

Meeting with Henna Virkkunen (Member of the European Parliament, Rapporteur for opinion) and 2 other interest representatives

20 Oct 2023 · Medicinal products for human use

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and 5 other interest representatives

13 Oct 2023 · Directive on Medicinal products for human use

Meeting with Catherine Amalric (Member of the European Parliament, Shadow rapporteur) and Bureau Européen des Unions de Consommateurs

21 Sept 2023 · Reform of the EU pharmaceutical legislation

Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur)

13 Sept 2023 · Pharmaceutical legislation

Meeting with Tom Vandenkendelaere (Member of the European Parliament)

4 Sept 2023 · general introduction, pharmaceutical review

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and 11 other interest representatives

18 Jul 2023 · Directive on Medicinal products for human use

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and European Social Insurance Platform AISBL

5 Jun 2023 · Revision of Pharmaceutical Legislation (staff level)

Meeting with István Ujhelyi (Member of the European Parliament) and Vaccines Europe

24 May 2023 · Health

Meeting with Miapetra Kumpula-Natri (Member of the European Parliament)

23 May 2023 · Meeting on EU's pharmaceutical legislation

Meeting with Sirpa Pietikäinen (Member of the European Parliament)

23 May 2023 · EU Medical Devices Legislation

Meeting with Nathalie Colin-Oesterlé (Member of the European Parliament) and Moderna, Inc.

3 May 2023 · Pharmaceutical review

Meeting with Pascal Arimont (Member of the European Parliament)

23 Mar 2023 · Cardiovascular diseases and diabetes

Meeting with Axel Voss (Member of the European Parliament, Shadow rapporteur) and 124 other interest representatives

8 Mar 2023 · Corporate Sustainability Due Diligence

Meeting with Kevin Keary (Cabinet of Executive Vice-President Valdis Dombrovskis) and 2 other interest representatives

6 Mar 2023 · Pharma package

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

1 Mar 2023 · Medicines

Meeting with István Ujhelyi (Member of the European Parliament) and Eli Lilly and Company

1 Mar 2023 · Cardiovascular Health

Meeting with Susana Solís Pérez (Member of the European Parliament)

1 Mar 2023 · NCDs

Meeting with Maria Luisa Llano Cardenal (Cabinet of Vice-President Margaritis Schinas)

13 Feb 2023 · EU strategic autonomy in the health sector

Meeting with Lucrezia Busa (Cabinet of Commissioner Didier Reynders), Ludovic Pierre (Cabinet of Commissioner Didier Reynders)

10 Jan 2023 · Commission Proposal for Directive on sustainability - Due Diligence (CSDDD)

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

30 Nov 2022 · Medicines

Meeting with Romana Jerković (Member of the European Parliament)

7 Nov 2022 · Pharmaceutical legislation

Meeting with Antonius Manders (Member of the European Parliament)

13 Oct 2022 · Pharmaceutical Strategy

Meeting with Milan Brglez (Member of the European Parliament)

12 Oct 2022 · Revision of the EU general pharmaceuticals legislation

Meeting with Matjaž Nemec (Member of the European Parliament)

12 Oct 2022 · Revision of the EU general pharmaceuticals legislation

Meeting with Eszter Batta (Cabinet of Commissioner Thierry Breton), Maurits-Jan Prinz (Cabinet of Commissioner Thierry Breton)

6 Oct 2022 · Energy prices’ impact on generic medicines manufacturing

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the European Health Data Space

27 Jul 2022

Response to Proposal for a Regulation amending Regulations (EC) No 469/2009 and 1610/96 concerning supplementary protection certificates (SPCs) with a view to creating a unified granting procedure, and proposal for a Regulation creating a unitary SPC

5 Apr 2022

Meeting with Cyrus Engerer (Member of the European Parliament) and Pfizer Inc.

3 Dec 2021 · Joint Procurement of Medicines

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL LAYING DOWN HARMONISED RULES ON ARTIFICIAL INTELLIGENCE (ARTIFICIAL INTELLIGENCE ACT) AND AMENDING CERTAIN UNION LEGISLATIVE ACTS

5 Aug 2021

Meeting with Cyrus Engerer (Member of the European Parliament)

28 May 2021 · Newborn Screening

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Meeting with Carlo Fidanza (Member of the European Parliament)

17 Mar 2021 · Pharmaceutical Strategy

Meeting with Thierry Breton (Commissioner) and 1 other attendee

18 Feb 2021 · COVID-19 vaccines production

Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products

5 Jan 2021

Meeting with Irena Joveva (Member of the European Parliament)

11 Dec 2020 · Pharmaceutical strategy and digitalization of the healthcare system

Meeting with Eszter Batta (Cabinet of Commissioner Thierry Breton)

3 Sept 2020 · Keeping existing pharmaceutical manufacturing capacity in the EU

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

7 Jul 2020

Meeting with Stella Kyriakides (Commissioner)

7 Apr 2020 · Discussion on medicines (Production, clinical tests, supply and allocation)

Meeting with Stella Kyriakides (Commissioner) and 8 other attendees

5 Feb 2020 · Discussion on Cancer and Europe's Beating Cancer Plan

Meeting with Giulia Del Brenna (Cabinet of Commissioner Carlos Moedas)

27 Nov 2018 · Health research in Horizon Europe

Meeting with Nils Behrndt (Cabinet of Vice-President Neven Mimica)

27 Nov 2018 · Access to health services, including pharmaceuticals, in developing countries

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis) and SANOFI

21 Feb 2018 · HTA; Supplementary Protection Certificates (SPC)

Meeting with Fabrice Comptour (Cabinet of Commissioner Elżbieta Bieńkowska), Kaius Kristian Hedberg (Cabinet of Commissioner Elżbieta Bieńkowska) and 2 other attendees

15 Feb 2018 · pharmaceutical IP incentives

Meeting with Pierre Schellekens (Cabinet of Vice-President Miguel Arias Cañete)

1 Feb 2018 · Patent Issues

Meeting with Günther Oettinger (Commissioner)

25 Jan 2018 · health policy

Meeting with Lucie Mattera (Cabinet of Commissioner Pierre Moscovici) and SANOFI

25 Jan 2018 · European patent protection

Meeting with Tom Tynan (Cabinet of Commissioner Phil Hogan)

25 Jan 2018 · Business discussion

Meeting with Günther Oettinger (Commissioner)

21 Nov 2017 · research budget

Meeting with Jyrki Katainen (Vice-President) and 2 other interest representatives

21 Nov 2017 · Internal Market's industrial property legal framework relating to supplementary protection certificates (SPC) and patent research exemptions; innovation in the pharmaceutical industry

Meeting with Manuel Mateo Goyet (Cabinet of Commissioner Mariya Gabriel)

8 Nov 2017 · E Health

Meeting with Michael Karnitschnig (Cabinet of Vice-President Johannes Hahn)

8 Nov 2017 · Economy and Investment in the EU Neighbourhood

Meeting with Miguel Ceballos Baron (Cabinet of Vice-President Cecilia Malmström)

7 Nov 2017 · Innovation and patents in trade policy

Meeting with Andrus Ansip (Vice-President) and 1 other attendee

18 Jan 2017 · Data, e-health

Meeting with Bernardus Smulders (Cabinet of First Vice-President Frans Timmermans) and 36 other interest representatives

14 Jan 2016 · AECA Round-Table on “Dealing with Regulatory Burden

Meeting with Robert Madelin (Director-General Communications Networks, Content and Technology) and 22 other interest representatives

3 Jun 2015 · New College and Better Regulation

Meeting with Daniel Calleja Crespo (Director-General Internal Market, Industry, Entrepreneurship and SMEs)

13 Mar 2015 · Industrial Policy for pharmaceuticals

Meeting with Robert Madelin (Director-General Communications Networks, Content and Technology) and 11 other interest representatives

12 Feb 2015 · Digital Single Market, Innovation

Meeting with Carlos Moedas (Commissioner)

23 Jan 2015 · Bilateral meeting the CEO of Novartis & EFPIA President

Meeting with Věra Jourová (Commissioner) and 8 other interest representatives

16 Jan 2015 · Round Table on Gender Diversity